The IMPACT trial: Stopping the immune system from attacking insulin-producing cells
One key area of research for slowing and preventing the onset of type 1 diabetes (T1D) is understanding how to stop the immune system from attacking and destroying the cells in the pancreas that produce insulin.
What is the IMPACT Trial?
A new JDRF-funded study, known as the IMPACT trial, is testing if a new and experimental drug IMCY-0098 can help in this process.
The study is designed to determine if IMCY-0098 (which is injected) will trigger the production of new immune cells that can target and destroy the cells that damage the pancreas, intercepting the process before the body’s ability to produce insulin is impacted.
IMCY-0098 was found to be safe when tested on people recently diagnosed with T1D in its first clinical study, and the current trial is running to understand the most effective and efficient way to offer the treatment to people in the community.
How can I get involved and learn more about the trial?
The study is open to people between 18 and 45 years of age who meet specific requirements, including a recent T1D diagnosis (i.e., are within 9-weeks from their first administration of insulin). Trial sites are currently operating in Melbourne, and sites in Sydney and Brisbane will also be available in the coming months.
For more information about the trial, you can visit https://type1screen.org/trial-for-new-t1d-diagnosis/ or view the video.
If you think you may be eligible for this trial and are interested in participating, please email the study team at: email@example.com
This trial is a collaboration between Imcyse and INNODIA, supported by JDRF funding.
How your gift can help make history: Research that’s changing the future of type 1 diabetes
Type 1 diabetes (T1D) is a condition which currently affects over 130,000 Australians, with a further 8 people diagnosed each day. JDRF has a vision of turning these numbers to zero and creating a world where T1D does not exist. How? By supporting the most promising research focused on finding cures and improving lives until […]
JDRF advocate Shanna McGrath receives Mark Butler Local Legend Award
Each year during National Volunteers Week, the Minister for Health, Hon Mark Butler, announces the winners of the Mark Butler MP Volunteer Awards. These awards recognise the local volunteers in his electorate, Hindmarsh, who are dedicated to improving the needs of the community organisations they represent. JDRF advocate, Shanna McGrath, was diagnosed with T1D when […]
Our 2023 Volunteer of the Year winners
It’s National Volunteer Week and this year’s theme is ‘change makers’. At JDRF, we know that no change for type 1 diabetes (T1D) has happened without the dedication of volunteers across the community. We are an organisation who was founded by volunteers and is still powered by them, including (but not limited to!) our amazing […]
Dr Ki Wook Kim awarded JDRF Career Development Award to improve type 1 diabetes risk prediction
Dr Ki Wook Kim, a prominent Australian researcher and emerging leader in type 1 diabetes (T1D) research based at the UNSW Sydney, has been awarded a JDRF Career Development Award (CDA) with US $1M funding committed over the next five years. Dr Kim is one of only 13 Australians to ever receive the JDRF Career […]